Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GNOM vs HTEC overlap: 26% of top holdings shared

Bottom line

How much do GNOM and HTEC overlap?

26% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 26.6% of GNOM's assets and 12.9% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

GNOMHTEC
Weight overlap (top 25)26%
Shared holdings6
Weight in shared holdings26.6%12.9%
Total positions5163
Expense ratio0.5%0.68%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings GNOM and HTEC have in common

Holding% of GNOM% of HTECOverlap
Guardant Health, Inc.5.59%2.31%2.31%
Illumina, Inc.4.82%2.09%2.09%
Natera, Inc.4.15%2.23%2.23%
Arrowhead Pharmaceuticals, Inc.4.07%2.08%2.08%
Twist Bioscience Corp3.97%2.23%2.23%
Vertex Pharmaceuticals Incorporated3.95%1.91%1.91%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GNOM

  1. Biomarin Pharmaceutical Inc. — 4.09%
  2. Legend Biotech Corp — 4.05%
  3. Praxis Precision Medicines Inc — 4.01%
  4. CRISPR Therapeutics AG — 3.85%
  5. Veracyte Inc — 3.64%
  6. Qiagen N.V. — 3.54%
  7. BioNTech SE — 3.41%
  8. Bio-techne Corporation — 3.41%
  9. Moderna, Inc. — 3.28%
  10. 10X Genomics Inc — 3.23%
  11. Beam Therapeutics Inc — 3.09%
  12. Bnyrepos — 3.05%
  13. Eli Lilly And Company — 2.32%
  14. Ultragenyx Pharmaceutical Inc — 2.25%
  15. Caris Life Sciences, Inc. — 2.03%

Only in HTEC

  1. Caredx, Inc. — 2.68%
  2. Thermo Fisher Scientific Incorporated — 2.18%
  3. Medpace Holdings, Inc. — 2.12%
  4. Adaptive Biotechnologies Corporation — 2.11%
  5. Iqvia Holdings Inc — 2.10%
  6. Regeneron Pharmaceuticals, Inc. — 1.97%
  7. Glaukos Corporation — 1.92%
  8. Stryker Corporation — 1.91%
  9. Livanova Plc — 1.87%
  10. Siemens Healthineers AG — 1.85%
  11. Lonza Group AG — 1.85%
  12. Incyte Corporation — 1.80%
  13. Abbott Laboratories — 1.79%
  14. AxoGen, Inc. — 1.77%
  15. Boston Scientific Corporation — 1.73%

Asset mix

Asset typeGNOMHTEC
Stocks99.9%99.8%
Repurchase agreements3.1%—
Cash & short-term funds—0.2%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryGNOMHTEC
US99.1%82.9%
CH—5.0%
HK2.0%3.7%
DE—1.9%
GB1.8%1.1%
NL—1.6%
FR—1.6%
IT—1.3%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do GNOM and HTEC overlap?
About 26% by weight. 6 securities appear in both funds' top 25 holdings; they make up 26.6% of GNOM's assets and 12.9% of HTEC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do GNOM and HTEC have in common?
The largest shared holdings are Guardant Health, Inc., Natera, Inc., Twist Bioscience Corp, Illumina, Inc., Arrowhead Pharmaceuticals, Inc..
Should I own both GNOM and HTEC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, GNOM or HTEC?
HTEC is broader, with 63 positions versus 51 for GNOM. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.